Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Tumori|July 31, 2014
Early and prolonged response to pazopanib in a patient with multiple metastases from renal cell carcinoma: a case reportElisa Biasco, Andrea Antonuzzo, Claudia Cianci, et al.
Experimental Hematology & Oncology|March 28, 2017
Metastatic BRAF K601E-mutated melanoma reaches complete response to MEK inhibitor trametinib administered for over 36 monthsRiccardo Marconcini, Luca Galli, Andrea Antonuzzo, et al.
Human Vaccines & Immunotherapeutics|October 6, 2021
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanomaRiccardo Marconcini, Gaetano Pezzicoli, Luigia Stefania Stucci, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|March 1, 2018
EZH2 Expression in Intestinal Neuroendocrine TumorsPinuccia Faviana, Riccardo Marconcini, Sergio Ricci, et al.
Tumori|February 24, 2015
Small-bowel neuroendocrine tumor and retroperitoneal fibrosis: efficacy of octreotide and tamoxifenElisa Biasco, Andrea Antonuzzo, Luca Galli, et al.
Critical Reviews in Oncology/Hematology|January 31, 2024
The treatment of advanced melanoma: Current approaches and new challengesAndrea Boutros, Elena Croce, Marco Ferrari, et al.
Acta Dermato-Venereologica|April 13, 2018
Effect of Age on Melanoma Risk, Prognosis and Treatment ResponseSimone Ribero, Luigia Stefania Stucci, Elena Marra, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 31, 2023
Epidemiology of Merkel cell carcinoma in Tuscany (Italy), 2006-2021Cristian Fidanzi, Silviu Flavius Troaca, Giuseppe Nicolò Fanelli, et al.
Endocrine|July 24, 2020
Temozolomide alone or in combination with capecitabine in patients with advanced neuroendocrine neoplasms: an Italian multicenter real-world analysisFrancesca Spada, Patrick Maisonneuve, Caterina Fumagalli, et al.
Cancer|August 12, 2014
Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patientsLisa Derosa, Luca Galli, Paola Orlandi, et al.
Pageof 5